Qiwen Zeng
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tumor-derived ITIH2 activates PI3K\AKT pathway via THBS1 ubiquitination and promotes tumor angiogenesis in hepatocellular carcinoma.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: August 20, 2025
KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: June 03, 2025
DDX42 Enhances Hepatocellular Carcinoma Cell Proliferation, Radiation and Sorafenib Resistance via Regulating GRB2 RNA Maturation and Activating PI3K/AKT Pathway.
Journal: Journal of cellular and molecular medicine
Published: February 20, 2025
Histone lactylation facilitates MCM7 expression to maintain stemness and radio-resistance in hepatocellular carcinoma.
Journal: Biochemical pharmacology
Published: December 24, 2024
The Lactate-Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM-Dependent Mitochondrial Fatty Acid Synthesis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 01, 2024
RBM39 promotes hepatocarcinogenesis by regulating RFX1's alternative splicing and subsequent activation of integrin signaling pathway.
Journal: Oncogene
Published: September 17, 2024
UBAP2 contributes to radioresistance by enhancing homologous recombination through SLC27A5 ubiquitination in hepatocellular carcinoma.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: May 07, 2024
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation.
Journal: International journal of oncology
Published: November 27, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026